| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V30592 | ACHP Hydrochloride | 406209-26-5 | ACHP hydrochloride(also known as IKK-2 Inhibitor VIII), thehydrochloride salt of ACHP, is a novel, highly potent and selective IKK-β inhibitor with IC50 of 8.5 nM. |
|
V0756 | AZD3264 | 1609281-86-8 | AZD3264 (AZD-3264; AZD 3264) is a novel and potent inhibitor of IKK2 (IkappaBKinase/(IκB) with potential anti-inflammatory and anticancer activity. |
|
V0749 | BAY 11-7082 | 19542-67-7 | BAY 11-7082 (BAY-11-7082; BAY-117082) is a novel and potent NF-κB inhibitor with potential anti-inflammatory and anticancer activity. |
|
V0760 | Bay 11-7085 | 196309-76-9 | BAY 11-7085 (BAY-11-7085; BAY 117085) is a novel, potent, soluble, irreversible inhibitor of TNFα-induced IκBα phosphorylation with potential anticancer activity. |
|
V0755 | BMS-345541 | 445430-58-0 | BMS-345541 (BMS345541; BMS 345541) is a novel, highly potent andselectiveIKK-1/2inhibitorwith potential anticancer and anti-inflammatory activity. |
|
V0750 | IKK-16 (IKK Inhibitor VII; IKK 16) | 873225-46-8 | IKK-16 (also known as IKK Inhibitor VII; IKK-16; IKK16) is a novel, potent and selective IκBα kinase (IKK) inhibitor with potential anti-inflammatory activity. |
|
V87868 | IKKβ-IN-4 | 4815-35-4 | IKKβ-IN-4 (compound 14) is an IkappaB kinase-β (ikkβ) inhibitor with IC50 of 1.9 μM. |
|
V0752 | IMD 0354 | 978-62-1 | IMD-0354 (IMD0354; IMD-0354) is a novel, potent and selective IKKβ inhibitorwith potential anti-inflammatory activity. |
|
V82225 | Keap1-Nrf2-IN-8 | 2769963-54-2 | Keap1-Nrf2-IN-8 (compound 12d) is a potent Keap1-Nrf2 PPI (Keap1-Nrf2 protein-protein interaction) inhibitor (antagonist) with IC50 of 64.5 nM and 14.2 nM in FP and TR-FRET assays, respectively. |
|
V118451 | LLVK TFA | LLVK TFA is a selective IκB phosphorylation inhibitor. | |
|
V0757 | LY2409881 trihydrochloride | 946518-60-1 | LY2409881trihydrochloride (LY-2409881; LY 2409881), thetrihydrochloride salt of LY-2409881, is a novel, potent and selective IKK2 (IκB kinase β) inhibitor with potential anticancer and anti-inflammatory activity. |
|
V0753 | PS-1145 | 431898-65-6 | PS-1145 (PS1145) is a novel, potent and specific IKK (IκB kinase) inhibitor with anticancer activity. |
|
V0761 | SC-514 | 354812-17-2 | SC-514 (SC 514; SC514) is a novel, potent, orally bioactive, selective and reversible, and ATP-competitive IKK-2 inhibitor with potential anti-inflammatory activity. |
|
V145643 | TBK1 ligand 3 | 2115897-10-2 | TBK1 ligand 3 is a TBK1 ligand that can be used as a target protein ligand for the synthesis of PROTAC UNC8209 and UNC8461. |
|
V145644 | TBK1-IN-2 | 3075572-35-6 | TBK1-IN-2 is a potent TBK1 inhibitor (IC50: 775 pM). |
|
V51259 | TBK1/IKKε-IN-6 | 2306877-20-1 | dual TBK1 and IKKε inhibitor |
|
V0751 | TPCA-1 (GW-683965; GW683965) | 507475-17-4 | TPCA-1 (also known as TPCA1; GW-683965; GW683965)is novel, potent, and selective inhibitor of IKK-2 with potential anti-inflammatory activity. |
|
V0759 | WS6 | 1421227-53-3 | WS6 (WS6; WS 6) is a novel and potent small molecule modulator of β cell proliferation via modulation of Erb3 binding protein-1 (EBP1) and the IκB kinase pathway with important biological activity. |
|
V0758 | WS3 | 1421227-52-2 | WS-3 (WS3; WS 3) is a novel and potent small molecule modulatior of Erb3 binding protein-1 (EBP1) and the IκB (IkappaB) kinase with important biological activity. |
|
V11455 | Amlexanox (AA673; CHX3673) | 68302-57-8 | Amlexanox (Amoxanox; AA-673; CHX-3673) is a potent and selective IKKε and TBK1 inhibitor which acts asanti-inflammatory antiallergic immunomodulator used to treat recurrent aphthous ulcers (canker sores), and (in Japan) several inflammatory conditions. |